Molecular Biology Reagents

(S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC 50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical

(S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC 50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical

(S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC 50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical

(S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC 50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical

(S)-Chroman-4-ylamine hydrochloride.

(S)-Chroman-4-ylamine hydrochloride.

Biochem/physiol Actions (S)-CPP is an inhibitor of branched-chain &#945:-ketoacid dehydrogenase complex (BCKDC) kinase, also know as BDK, or keto acid dehydrogenase kinase. BDK is a negative regulator of BCKDC activity.

(S)-ESBA HCl is a potent and selective mouse/rat kynurenine aminotransferase II (KAT II) inhibitor.(S)-ESBA hydrochlorideis a mouse and rat KAT II inhibitor.

(S)-ESBA HCl is a potent and selective mouse/rat kynurenine aminotransferase II (KAT II) inhibitor.(S)-ESBA hydrochlorideis a mouse and rat KAT II inhibitor.

(S)-Ethyl 2-(4-benzylmorpholin-3-yl)acetate.

Reactant for synthesis of: DPP-4 inhibitors JAK2 inhibitors Serotonin and noradrenaline reuptake inhibitors Human tryptase inhibitors Anti-thrombotic nicecotamides Reactive for oxidative C-arylation of free (NH)-heterocycles via direct (sp3) C-H

Reactant for synthesis of: DPP-4 inhibitors JAK2 inhibitors Serotonin and noradrenaline reuptake inhibitors Human tryptase inhibitors Anti-thrombotic nicecotamides Reactive for oxidative C-arylation of free (NH)-heterocycles via direct (sp3) C-H